| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.095 | 0.002 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.12 | 0.002 |